Ricci V - Search Results

1

New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.

Marshall RL, Lloyd GS, Lawler AJ, Element SJ, Kaur J, Ciusa ML, Ricci V, Tschumi A, Kühne H, Alderwick LJ, Piddock LJV. Marshall RL, et al. Among authors: ricci v. mBio. 2020 Jul 14;11(4):e01340-20. doi: 10.1128/mBio.01340-20. mBio. 2020. PMID: 32665275 Free PMC article.

2

Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Everett MJ, Jin YF, Ricci V, Piddock LJ. Everett MJ, et al. Among authors: ricci v. Antimicrob Agents Chemother. 1996 Oct;40(10):2380-6. doi: 10.1128/AAC.40.10.2380. Antimicrob Agents Chemother. 1996. PMID: 8891148 Free PMC article.

3

Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.

Piddock LJ, Ricci V, McLaren I, Griggs DJ. Piddock LJ, et al. Among authors: ricci v. J Antimicrob Chemother. 1998 Jun;41(6):635-41. doi: 10.1093/jac/41.6.635. J Antimicrob Chemother. 1998. PMID: 9687102

4

Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.

Piddock LJ, Johnson M, Ricci V, Hill SL. Piddock LJ, et al. Among authors: ricci v. Antimicrob Agents Chemother. 1998 Nov;42(11):2956-60. doi: 10.1128/AAC.42.11.2956. Antimicrob Agents Chemother. 1998. PMID: 9797232 Free PMC article.

5

Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.

Piddock LJ, Jin YF, Ricci V, Asuquo AE. Piddock LJ, et al. Among authors: ricci v. J Antimicrob Chemother. 1999 Jan;43(1):61-70. doi: 10.1093/jac/43.1.61. J Antimicrob Chemother. 1999. PMID: 10381102

6

Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.

Piddock LJ, Williams KJ, Ricci V. Piddock LJ, et al. Among authors: ricci v. J Antimicrob Chemother. 2000 Feb;45(2):159-65. doi: 10.1093/jac/45.2.159. J Antimicrob Chemother. 2000. PMID: 10660497

7

Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis.

Piddock LJ, Ricci V. Piddock LJ, et al. Among authors: ricci v. J Antimicrob Chemother. 2000 May;45(5):681-4. doi: 10.1093/jac/45.5.681. J Antimicrob Chemother. 2000. PMID: 10797093

8

Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK.

Piddock LJ, Ricci V, Stanley K, Jones K. Piddock LJ, et al. Among authors: ricci v. J Antimicrob Chemother. 2000 Aug;46(2):303-6. doi: 10.1093/jac/46.2.303. J Antimicrob Chemother. 2000. PMID: 10933658

9

Accumulation of norfloxacin by Bacteroides fragilis.

Ricci V, Piddock LJ. Ricci V, et al. Antimicrob Agents Chemother. 2000 Sep;44(9):2361-6. doi: 10.1128/AAC.44.9.2361-2366.2000. Antimicrob Agents Chemother. 2000. PMID: 10952580 Free PMC article.

10

Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.

Piddock LJ, Ricci V. Piddock LJ, et al. Among authors: ricci v. J Antimicrob Chemother. 2001 Dec;48(6):787-91. doi: 10.1093/jac/48.6.787. J Antimicrob Chemother. 2001. PMID: 11733462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters